Publication:
Serum IL-23 levels in patients with vitiligo

No Thumbnail Available

Date

2014-12-01T00:00:00Z

Authors

Cengiz, FATMA PELİN
Emiroglu, NAZAN
CEMIL, Bengu Cevirgen
ERDEM, Ummu Gul Bahar
KEMERIZ, Funda

Journal Title

Journal ISSN

Volume Title

Publisher

Research Projects

Organizational Units

Journal Issue

Metrics

Search on Google Scholar

Abstract

Background and Design: Interleukin-23 (IL-23) is a cytokine which is believed to have an important role in the pathogenesis of autoimmune diseases. Therefore, it can be used as a target molecule in the treatment of autoimmune diseases. The aim of our study was to determine serum IL-23 levels in patients with vitiligo to understand their possible roles in the disease etiology and to compare the results with the healthy controls.

Description

Keywords

Citation

Cengiz F. P. , Emiroglu N., CEMIL B. C. , ERDEM U. G. B. , KEMERIZ F., -Serum IL-23 levels in patients with vitiligo-, TURKDERM-ARCHIVES OF THE TURKISH DERMATOLOGY AND VENEROLOGY, cilt.48, ss.204-207, 2014

Collections

Page Views

0

File Downloads

0

Sustainable Development Goals